165 related articles for article (PubMed ID: 22167195)
1. Late SV40 factor (LSF) enhances angiogenesis by transcriptionally up-regulating matrix metalloproteinase-9 (MMP-9).
Santhekadur PK; Gredler R; Chen D; Siddiq A; Shen XN; Das SK; Emdad L; Fisher PB; Sarkar D
J Biol Chem; 2012 Jan; 287(5):3425-32. PubMed ID: 22167195
[TBL] [Abstract][Full Text] [Related]
2. Transcription factor Late SV40 Factor (LSF) functions as an oncogene in hepatocellular carcinoma.
Yoo BK; Emdad L; Gredler R; Fuller C; Dumur CI; Jones KH; Jackson-Cook C; Su ZZ; Chen D; Saxena UH; Hansen U; Fisher PB; Sarkar D
Proc Natl Acad Sci U S A; 2010 May; 107(18):8357-62. PubMed ID: 20404171
[TBL] [Abstract][Full Text] [Related]
3. The transcription factor LSF: a novel oncogene for hepatocellular carcinoma.
Santhekadur PK; Rajasekaran D; Siddiq A; Gredler R; Chen D; Schaus SE; Hansen U; Fisher PB; Sarkar D
Am J Cancer Res; 2012; 2(3):269-85. PubMed ID: 22679558
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-29b suppresses tumor angiogenesis, invasion, and metastasis by regulating matrix metalloproteinase 2 expression.
Fang JH; Zhou HC; Zeng C; Yang J; Liu Y; Huang X; Zhang JP; Guan XY; Zhuang SM
Hepatology; 2011 Nov; 54(5):1729-40. PubMed ID: 21793034
[TBL] [Abstract][Full Text] [Related]
5. c-Met activation through a novel pathway involving osteopontin mediates oncogenesis by the transcription factor LSF.
Yoo BK; Gredler R; Chen D; Santhekadur PK; Fisher PB; Sarkar D
J Hepatol; 2011 Dec; 55(6):1317-24. PubMed ID: 21703197
[TBL] [Abstract][Full Text] [Related]
6. Small molecule inhibitors of Late SV40 Factor (LSF) abrogate hepatocellular carcinoma (HCC): Evaluation using an endogenous HCC model.
Rajasekaran D; Siddiq A; Willoughby JL; Biagi JM; Christadore LM; Yunes SA; Gredler R; Jariwala N; Robertson CL; Akiel MA; Shen XN; Subler MA; Windle JJ; Schaus SE; Fisher PB; Hansen U; Sarkar D
Oncotarget; 2015 Sep; 6(28):26266-77. PubMed ID: 26313006
[TBL] [Abstract][Full Text] [Related]
7. Regulation of angiogenesis and invasion by human Pituitary tumor transforming gene (PTTG) through increased expression and secretion of matrix metalloproteinase-2 (MMP-2).
Malik MT; Kakar SS
Mol Cancer; 2006 Nov; 5():61. PubMed ID: 17096843
[TBL] [Abstract][Full Text] [Related]
8. The transcription factor ZFHX3 is crucial for the angiogenic function of hypoxia-inducible factor 1α in liver cancer cells.
Fu C; An N; Liu J; A J; Zhang B; Liu M; Zhang Z; Fu L; Tian X; Wang D; Dong JT
J Biol Chem; 2020 May; 295(20):7060-7074. PubMed ID: 32277050
[TBL] [Abstract][Full Text] [Related]
9. Characterization of genome-wide TFCP2 targets in hepatocellular carcinoma: implication of targets FN1 and TJP1 in metastasis.
Xu X; Liu Z; Zhou L; Xie H; Cheng J; Ling Q; Wang J; Guo H; Wei X; Zheng S
J Exp Clin Cancer Res; 2015 Jan; 34(1):6. PubMed ID: 25609232
[TBL] [Abstract][Full Text] [Related]
10. KDM5A silencing transcriptionally suppresses the FXYD3-PI3K/AKT axis to inhibit angiogenesis in hepatocellular cancer via miR-433 up-regulation.
Ma YS; Wu TM; Qian B; Liu YS; Ding H; Fan MM; Liu JB; Yu F; Wang HM; Shi Y; Gu LP; Li L; Tian LL; Wang PY; Wang GR; Wu ZJ; Zou QF; Ling CC; Fu D
J Cell Mol Med; 2021 Apr; 25(8):4040-4052. PubMed ID: 33621431
[TBL] [Abstract][Full Text] [Related]
11. The ETS transcription factor MEF is a candidate tumor suppressor gene on the X chromosome.
Seki Y; Suico MA; Uto A; Hisatsune A; Shuto T; Isohama Y; Kai H
Cancer Res; 2002 Nov; 62(22):6579-86. PubMed ID: 12438253
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of vascular endothelial growth factor by membrane-type 1 matrix metalloproteinase stimulates human glioma xenograft growth and angiogenesis.
Deryugina EI; Soroceanu L; Strongin AY
Cancer Res; 2002 Jan; 62(2):580-8. PubMed ID: 11809713
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor-binding protein-7 functions as a potential tumor suppressor in hepatocellular carcinoma.
Chen D; Yoo BK; Santhekadur PK; Gredler R; Bhutia SK; Das SK; Fuller C; Su ZZ; Fisher PB; Sarkar D
Clin Cancer Res; 2011 Nov; 17(21):6693-701. PubMed ID: 21908579
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA UBE2CP3 enhances HCC cell secretion of VEGFA and promotes angiogenesis by activating ERK1/2/HIF-1α/VEGFA signalling in hepatocellular carcinoma.
Lin J; Cao S; Wang Y; Hu Y; Liu H; Li J; Chen J; Li P; Liu J; Wang Q; Zheng L
J Exp Clin Cancer Res; 2018 Jun; 37(1):113. PubMed ID: 29866133
[TBL] [Abstract][Full Text] [Related]
15. Antiproliferative small-molecule inhibitors of transcription factor LSF reveal oncogene addiction to LSF in hepatocellular carcinoma.
Grant TJ; Bishop JA; Christadore LM; Barot G; Chin HG; Woodson S; Kavouris J; Siddiq A; Gredler R; Shen XN; Sherman J; Meehan T; Fitzgerald K; Pradhan S; Briggs LA; Andrews WH; Sarkar D; Schaus SE; Hansen U
Proc Natl Acad Sci U S A; 2012 Mar; 109(12):4503-8. PubMed ID: 22396589
[TBL] [Abstract][Full Text] [Related]
16. A novel binding factor of 14-3-3beta functions as a transcriptional repressor and promotes anchorage-independent growth, tumorigenicity, and metastasis.
Komiya Y; Kurabe N; Katagiri K; Ogawa M; Sugiyama A; Kawasaki Y; Tashiro F
J Biol Chem; 2008 Jul; 283(27):18753-64. PubMed ID: 18460465
[TBL] [Abstract][Full Text] [Related]
17. Suppression of alpha-tocopherol ether-linked acetic acid in VEGF-induced angiogenesis and the possible mechanisms in human umbilical vein endothelial cells.
Chuang CH; Liu CH; Lu TJ; Hu ML
Toxicol Appl Pharmacol; 2014 Dec; 281(3):310-6. PubMed ID: 25447407
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of microRNA-338-3p promoted angiogenesis in hepatocellular carcinoma.
Zhang T; Liu W; Zeng XC; Jiang N; Fu BS; Guo Y; Yi HM; Li H; Zhang Q; Chen WJ; Chen GH
Biomed Pharmacother; 2016 Dec; 84():583-591. PubMed ID: 27694002
[TBL] [Abstract][Full Text] [Related]
19. Late SV40 factor: a key mediator of Notch signaling in human hepatocarcinogenesis.
Fan RH; Li J; Wu N; Chen PS
World J Gastroenterol; 2011 Aug; 17(29):3420-30. PubMed ID: 21876634
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA HULC promotes tumor angiogenesis in liver cancer by up-regulating sphingosine kinase 1 (SPHK1).
Lu Z; Xiao Z; Liu F; Cui M; Li W; Yang Z; Li J; Ye L; Zhang X
Oncotarget; 2016 Jan; 7(1):241-54. PubMed ID: 26540633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
